Raia Drogasil S.A.

São Paulo Stock Exchange RADL3.SA

Raia Drogasil S.A. Receivables for the year ending December 31, 2023: USD 634.57 M

Raia Drogasil S.A. Receivables is USD 634.57 M for the year ending December 31, 2023, a 46.72% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Raia Drogasil S.A. Receivables for the year ending December 31, 2022 was USD 432.50 M, a 41.21% change year over year.
Raia Drogasil S.A. Receivables for the year ending December 31, 2021 was USD 306.27 M, a -15.10% change year over year.
Raia Drogasil S.A. Receivables for the year ending December 31, 2020 was USD 360.76 M, a -8.06% change year over year.
Raia Drogasil S.A. Receivables for the year ending December 31, 2019 was USD 392.40 M, a 29.39% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

São Paulo Stock Exchange: RADL3.SA

Raia Drogasil S.A.

CEO	Mr. Marcílio D'Amigo Pousada
IPO Date	Jan. 6, 2000
Location	Brazil
Headquarters	Av. Corifeu de Azevedo Marques, 3097
Employees	62,402
Sector	Health Care
Industries Drugstores & Retail Pharmacies Cosmetics Pharmaceuticals Specialty Retail

Description

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Key trends

Past 5 years